The molecular mechanism for adiponectin down-regulation is not clear but it is known that GDM is characterized by an amplification of the inflammatory state during pregnancy; this causes an increase in the circulating levels of many inflammatory cytokines including TNF-α and IL-6 which are negative regulators of the adiponectin expression [73]. The gene discussed is ADIPOQ; the disease is gestational diabetes.